Contrad Swiss is the most innovative pharmaceutical corporation specialized in OTC, medical devices, functional cosmetics, and dietary supplements. We focus on products that reframe the world of medicine.
Contrad brings SIGMOLECS® Technology to the market, taking the current use of peptides as active ingredients a giant step forward. SIGMOLECS® coded peptides mimic the action of endogenous signalling molecules. They are stable and highly penetrating which translates to increased bioavailability, a key determinant of the efficacy of our products.
Our lines are powered by SIGMOLECS®.